FDA
FDA Guidance on Considerations for Weight Loss Devices: Treatment Protocols, Endpoints and Adverse Events
The article describes in detail the approach to be applied with respect to clinical performance testing considerations including, inter alia, the ones associated with treatment parameters and protocols, safety and effectiveness endpoints and data, as well as adverse events
